C07D 233/24
Radicals substituted by nitrogen atoms not forming part of a nitro radical
C07D233/24 (Radicals substituted by nitrogen atoms not forming part of a nitro radical) appears on 160 US grants and 137 published applications in this corpus.
Search patents in C07D- Granted patents
- 160
- Published applications
- 137
- Assignees
- 116
- Inventors
- 560
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 4 | 0 |
| 1979 | 3 | 0 |
| 1980 | 2 | 0 |
| 1981 | 5 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 6 | 0 |
| 2001 | 5 | 1 |
| 2002 | 6 | 5 |
| 2003 | 4 | 8 |
| 2004 | 5 | 8 |
| 2005 | 6 | 12 |
| 2006 | 2 | 10 |
| 2007 | 4 | 7 |
| 2008 | 6 | 8 |
| 2009 | 5 | 15 |
| 2010 | 7 | 2 |
| 2011 | 6 | 6 |
| 2012 | 3 | 4 |
| 2013 | 6 | 5 |
| 2014 | 5 | 4 |
| 2015 | 2 | 3 |
| 2016 | 2 | 2 |
| 2017 | 4 | 8 |
| 2018 | 3 | 2 |
| 2019 | 2 | 1 |
| 2020 | 4 | 6 |
| 2021 | 2 | 6 |
| 2022 | 6 | 4 |
| 2023 | 3 | 2 |
| 2024 | 2 | 3 |
| 2025 | 1 | 3 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Highly pure phentolamine mesylate and methods for making same15 Sep 2026US 12,735,389 B2Opus Genetics, Inc.
- Pourable wetting agents and methods associated therewith12 May 2026US 12,624,272 B2Saudi Arabian Oil Company
- Methods and materials for increasing level of phosphorylated AMPK protein30 Sep 2025US 12,428,378 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Highly pure phentolamine mesylate7 May 2024US 11,976,044 B2Ocuphire Pharma, Inc.
- Sphingosine kinase inhibitors23 Jan 2024US RE49,811 E1Apogee Biotechnology Corporation
- Pourable wetting agents and methods associated therewith13 Aug 2026US 2026/0234462 A1Aramco Americas Company
- Methods and materials for increasing level of phosphorylated ampk protein21 May 2026US 2026/0138955 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Pourable wetting agents and methods associated therewith4 Dec 2025US 2025/0368881 A1Saudi Arabian Oil Company
- Phentolamine mesylate and therapeutic uses thereof22 May 2025US 2025/0162995 A1Opus Genetics, Inc.
- Claudin inhibitors and methods of use thereof15 May 2025US 2025/0154110 A1The Board of Trustees of the University of Illinois
Most cited
By later US patents
- Mutilin derivatives and their use as antibacterials115US 7,534,814 B2Nabriva Therapeutics AG · 2009
- Arylsulfonamido-substituted hydroxamic acids110US 5,455,258 ACiba-Geigy Corporation · 1995
- Arylsulfonamido-substituted hydroxamic acids85US 5,552,419 ACiba-Geigy Corporation · 1996
- Arylsufonamido-substituted hydroxamic acids78US 5,506,242 ACiba-Geigy Corporation · 1996
- Cis-imidazolines63US 6,734,302 B2Hoffmann-La Roche Inc. · 2004